Susan Kempe-Mueller

Dr. Kempe-Müller’s experience includes advising: 

• Cheplapharm on the acquisition of the US Marketing Authorization for Pulmicort Flexhaler, a Budesonide inhalation powder for the treatment of Asthma, from AstraZeneca AB
• Deutsche Bank and Orchard Global Asset Management on the sale of HIT Holzindustrie Torgau to Mercer International Inc.
• HANNOVER Finanz and Hans-Werner Mumm on the sale of their shares in ATEC
• Hg on the sale of Transporeon
• Partners Group on the acquisition of a majority stake in Cloudflight
• Triton on the acquisition of Trench

Thought Leadership

• Börsen-Zeitung, April 2021 “Tight corset: How the EU regulates artificial intelligence”
• Börsen-Zeitung, July 2021 “Legislator wants to stop patent trolls”
• Börsen-Zeitung, October 2021 “Europe finally gets uniform patent protection”
• Börsen-Zeitung, June 2022 “Free access to data of connected devices and machines”
• Börsen-Zeitung, May 2023 “Taking a close look at the data pool in due diligence”
• Frankfurter Allgemeine Zeitung, May 2023 “The Winner Takes It All”